250 related articles for article (PubMed ID: 18829682)
1. MMP expression and abnormal lung permeability are important determinants of outcome in IPF.
McKeown S; Richter AG; O'Kane C; McAuley DF; Thickett DR
Eur Respir J; 2009 Jan; 33(1):77-84. PubMed ID: 18829682
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis.
Craig VJ; Zhang L; Hagood JS; Owen CA
Am J Respir Cell Mol Biol; 2015 Nov; 53(5):585-600. PubMed ID: 26121236
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-10: a novel biomarker for idiopathic pulmonary fibrosis.
Sokai A; Handa T; Tanizawa K; Oga T; Uno K; Tsuruyama T; Kubo T; Ikezoe K; Nakatsuka Y; Tanimura K; Muro S; Hirai T; Nagai S; Chin K; Mishima M
Respir Res; 2015 Sep; 16():120. PubMed ID: 26415518
[TBL] [Abstract][Full Text] [Related]
4. [Change of matrix metalloproteinase-1 and matrix metalloproteinase-7 in serum and bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and sarcoidosis].
Zhou LF; Jiang L; Li ZH; Kang J
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jun; 33(6):441-4. PubMed ID: 20979817
[TBL] [Abstract][Full Text] [Related]
5. [Changes of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in the bronchoalveolar lavage fluid and the serum of patients with idiopathic pulmonary fibrosis].
Wei LQ; Li ZH; Kang J; Hou XM; Yu RJ
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jun; 29(6):399-402. PubMed ID: 17045024
[TBL] [Abstract][Full Text] [Related]
6. Time course of matrix metalloproteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis.
Oggionni T; Morbini P; Inghilleri S; Palladini G; Tozzi R; Vitulo P; Fenoglio C; Perlini S; Pozzi E
Eur J Histochem; 2006; 50(4):317-25. PubMed ID: 17213041
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition.
Milara J; Navarro R; Juan G; Peiró T; Serrano A; Ramón M; Morcillo E; Cortijo J
Thorax; 2012 Feb; 67(2):147-56. PubMed ID: 22106015
[TBL] [Abstract][Full Text] [Related]
8. Localization of matrix metalloproteinases, (MMPs) their tissue inhibitors, and vascular endothelial growth factor (VEGF) in growth plates of children and adolescents indicates a role for MMPs in human postnatal growth and skeletal maturation.
Haeusler G; Walter I; Helmreich M; Egerbacher M
Calcif Tissue Int; 2005 May; 76(5):326-35. PubMed ID: 15868281
[TBL] [Abstract][Full Text] [Related]
9. Elevated matrilysin levels in bronchoalveolar lavage fluid do not distinguish idiopathic pulmonary fibrosis from other interstitial lung diseases.
Vuorinen K; Myllärniemi M; Lammi L; Piirilä P; Rytilä P; Salmenkivi K; Kinnula VL
APMIS; 2007 Aug; 115(8):969-75. PubMed ID: 17696954
[TBL] [Abstract][Full Text] [Related]
10. Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort.
Todd JL; Vinisko R; Liu Y; Neely ML; Overton R; Flaherty KR; Noth I; Newby LK; Lasky JA; Olman MA; Hesslinger C; Leonard TB; Palmer SM; Belperio JA;
BMC Pulm Med; 2020 Mar; 20(1):64. PubMed ID: 32171287
[TBL] [Abstract][Full Text] [Related]
11. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N
Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
[TBL] [Abstract][Full Text] [Related]
12. Is metalloproteinase-7 specific for idiopathic pulmonary fibrosis?
Huh JW; Kim DS; Oh YM; Shim TS; Lim CM; Lee SD; Koh Y; Kim WS; Kim WD; Kim KR
Chest; 2008 May; 133(5):1101-6. PubMed ID: 18071010
[TBL] [Abstract][Full Text] [Related]
13. Pivotal role of matrix metalloproteinase 13 in extracellular matrix turnover in idiopathic pulmonary fibrosis.
Nkyimbeng T; Ruppert C; Shiomi T; Dahal B; Lang G; Seeger W; Okada Y; D'Armiento J; Günther A
PLoS One; 2013; 8(9):e73279. PubMed ID: 24023851
[TBL] [Abstract][Full Text] [Related]
14. Basement membrane remodeling in skeletal muscles of patients with limb ischemia involves regulation of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases.
Baum O; Ganster M; Baumgartner I; Nieselt K; Djonov V
J Vasc Res; 2007; 44(3):202-13. PubMed ID: 17337906
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor increases pulmonary vascular permeability in cystic fibrosis patients undergoing lung transplantation.
Krenn K; Klepetko W; Taghavi S; Paulus P; Aharinejad S
Eur J Cardiothorac Surg; 2007 Jul; 32(1):35-41. PubMed ID: 17481912
[TBL] [Abstract][Full Text] [Related]
16. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
Adya R; Tan BK; Punn A; Chen J; Randeva HS
Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986
[TBL] [Abstract][Full Text] [Related]
17. Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage.
Manetti M; Guiducci S; Romano E; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2012 Jun; 71(6):1064-72. PubMed ID: 22258486
[TBL] [Abstract][Full Text] [Related]
18. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.
Kim TH; Lee YH; Kim KH; Lee SH; Cha JY; Shin EK; Jung S; Jang AS; Park SW; Uh ST; Kim YH; Park JS; Sin HG; Youm W; Koh ES; Cho SY; Paik YK; Rhim TY; Park CS
Am J Respir Crit Care Med; 2010 Sep; 182(5):633-42. PubMed ID: 20463180
[TBL] [Abstract][Full Text] [Related]
19. [The mechanism of lung tissue remodeling in the progression of idiopathic pulmonary fibrosis].
Kogan EA; Tyong FV; Demura SA
Arkh Patol; 2010; 72(4):30-6. PubMed ID: 21086635
[TBL] [Abstract][Full Text] [Related]
20. Serum metalloproteinases 1 and 7 in the diagnosis of idiopathic pulmonary fibrosis and other interstitial pneumonias.
Morais A; Beltrão M; Sokhatska O; Costa D; Melo N; Mota P; Marques A; Delgado L
Respir Med; 2015 Aug; 109(8):1063-8. PubMed ID: 26174192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
